Intraocular lenses (IOLs) that block both ultraviolet (UV) radiation and blue visible light were introduced for use in cataract surgery in the 1990s. It was believed that the light-absorbing nature of these lens implants might offer advantages over clear lens implants, including providing sharper vision, better contrast sensitivity and reduced risk of macular degeneration.
